TTrialPathMatch Me to Trials
← Back to trials
RecruitingObesity and Type 2 Diabetes

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Eligible age

14–16 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Hispanic adolescents are disproportionately burdened by type 2 diabetes (T2D). Social determinants of health (SDoH) serve as barriers to behavior change and participation in disease prevention efforts, especially among vulnerable adolescents. Telehealth is a potentially effective approach for delivering disease prevention programs as it addresses some SDoH like transportation, childcare needs, and parent work schedules. Unfortunately, there are no theory- or evidence-based telehealth diabetes prevention program for Hispanic adolescents. Therefore the purpose of this study is to adapt an evidence-based diabetes prevention program for delivery via telehealth and to test the feasibility of this study among Hispanic adolescents (12-16 years) with obesity.

Sponsor: Baylor College of Medicine

You may qualify if…

  • Self-report as Hispanic
  • obese, defined as body mass index percentile (BMI%) ≥ 95th percentile
  • ages of 12-16 years
  • owns his or her own cellphone

You may not qualify if…

  • Taking a medication (i.e. steroids) or diagnosed with a condition (i.e. sleep apnea) that influences activity, sleep, and/or cognition
  • Recent hospitalization or injury that prevents normal physical activity
  • Pregnant
  • Currently enrolled in an exercise program or currently using a personal activity monitoring device like Fitbit
  • Taking medications or diagnosed with a condition that influences activity, glucose metabolism, and/or cognition.

Where it's recruiting

Texas

Houston

Source: ClinicalTrials.gov · NCT06943001 · last updated 2026-07-07

Adapting and Assessing the Feasibility of a Telehealth Diabetes Preven · TrialPath